A61P 1/18
Drugs for disorders of the alimentary tract or the digestive system: for
Official title: for pancreatic disorders, e.g. pancreatic enzymes
A61P1/18 (Drugs for disorders of the alimentary tract or the digestive system: for) appears on 5,257 US grants and 8,243 published applications in this corpus.
Search patents in A61P- Granted patents
- 5,257
- Published applications
- 8,243
- Assignees
- 2,281
- Inventors
- 13,160
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 5 | 0 |
| 1998 | 11 | 0 |
| 1999 | 20 | 0 |
| 2000 | 31 | 0 |
| 2001 | 50 | 14 |
| 2002 | 75 | 108 |
| 2003 | 75 | 217 |
| 2004 | 65 | 300 |
| 2005 | 66 | 273 |
| 2006 | 100 | 286 |
| 2007 | 119 | 322 |
| 2008 | 140 | 377 |
| 2009 | 158 | 499 |
| 2010 | 248 | 563 |
| 2011 | 279 | 490 |
| 2012 | 357 | 513 |
| 2013 | 440 | 462 |
| 2014 | 396 | 490 |
| 2015 | 335 | 397 |
| 2016 | 302 | 490 |
| 2017 | 349 | 454 |
| 2018 | 317 | 413 |
| 2019 | 315 | 340 |
| 2020 | 272 | 324 |
| 2021 | 189 | 203 |
| 2022 | 156 | 222 |
| 2023 | 112 | 188 |
| 2024 | 117 | 132 |
| 2025 | 93 | 102 |
| 2026 | 53 | 64 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic uses of inhibitors of the RNA-binding protein HuR6 Oct 2026US 12,751,938 B2University of Kansas
- Ulinastatin polypeptides8 Sep 2026US 12,729,233 B2DiaMedica USA Inc.
- Multi-transgenic pig for Xenotransplantation25 Aug 2026US 12,714,077 B2Revivicor, Inc.
- Compositions and methods for cancer therapy25 Aug 2026US 12,714,723 B2AIM ImmunoTech Inc.
- Bi-specific fusion proteins25 Aug 2026US 12,715,937 B2Silver Creek Pharmaceuticals, Inc.
- Humanized Anti-GPC-1 Antibody24 Sep 2026US 2026/0286004 A1Iwate Medical University
- Dual inhibitor trypsin antibodies and uses thereof17 Sep 2026US 2026/0274991 A1Triveni Bio, Inc.
- Lipid nanoparticles27 Aug 2026US 2026/0248824 A1Shizuoka Prefectural University Corporation
- Combination of anti-cdh6 antibody-drug conjugate and hif-2alpha inhibitor27 Aug 2026US 2026/0248938 A1Daiichi Sankyo Company, Limited
- Bromodomain Inhibitors27 Aug 2026US 2026/0250279 A1AbbVie Inc.
Most cited
By later US patents
- Inhibitors of bruton's tyrosine kinase306US 7,514,444 B2Pharmacyclics, Inc. · 2009
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Methods of making conditioned cell culture medium compositions249US 6,372,494 B1Advanced Tissue Sciences, Inc. · 2002
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor220US 7,790,449 B2The Trustees of the University of Pennsylvania · 2010
- Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases219US 6,482,834 B2Aventis Pharmaceuticals Inc. · 2002